- Filed
- Nov 3, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 2, 2025 | 586.4M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 588.2M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 588.1M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 587.6M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 587.7M sh |
| Dividends Paid | Q3 2025 · Sep 30, 2025 | $2.81B |
| Dividends Paid restated | Q3 2025 · Sep 30, 2024 | $615M |
| Capex | Q3 2025 · Sep 30, 2025 | $227M |
| Capex restated | Q3 2025 · Sep 30, 2024 | $175M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $14.38B |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | $12.11B |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $0 |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $0 |
| Short Term Debt | Q3 2025 · Sep 30, 2024 | $0 |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $1.52B |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $615M |
| Short Term Investments restated | Q3 2025 · Sep 30, 2024 | $757M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $185M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $154M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $147M |
| Cash And Equivalents restated | Q3 2025 · Dec 31, 2023 | $100M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $35.45B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $25.59B |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $27.16B |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $86.09B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $80.15B |
| Total Liabilities restated | Q3 2025 · Sep 30, 2024 | $78.04B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $121.54B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $105.75B |
| Total Assets restated | Q3 2025 · Sep 30, 2024 | $105.2B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $4.45 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $14.21 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $3.97 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $10.39 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $4.46 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $14.25 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $3.98 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $10.43 |
| Net Income | Q3 2025 · Sep 30, 2025 | $2.62B |
| Net Income | Q3 2025 · Sep 30, 2025 | $8.36B |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $2.33B |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $6.12B |
| Revenue | Q3 2025 · Sep 30, 2025 | $22.51B |
| Revenue | Q3 2025 · Sep 30, 2025 | $64.93B |
| Revenue | Q3 2025 · Sep 30, 2024 | $19.72B |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $55.1B |